217 related articles for article (PubMed ID: 20835434)
1. Water soluble nanoporous nanoparticle for in vivo targeted drug delivery and controlled release in B cells tumor context.
De Angelis F; Pujia A; Falcone C; Iaccino E; Palmieri C; Liberale C; Mecarini F; Candeloro P; Luberto L; de Laurentiis A; Das G; Scala G; Di Fabrizio E
Nanoscale; 2010 Oct; 2(10):2230-6. PubMed ID: 20835434
[TBL] [Abstract][Full Text] [Related]
2. Effect of molecular weight on the oleoyl-chitosan nanoparticles as carriers for doxorubicin.
Zhang J; Chen XG; Sun GZ; Huang L; Cheng XJ
Colloids Surf B Biointerfaces; 2010 Jun; 77(2):125-30. PubMed ID: 20172698
[TBL] [Abstract][Full Text] [Related]
3. Characterization and preparation of core-shell type nanoparticle for encapsulation of anticancer drug.
Jang MK; Jeong YI; Nah JW
Colloids Surf B Biointerfaces; 2010 Dec; 81(2):530-6. PubMed ID: 20801624
[TBL] [Abstract][Full Text] [Related]
4. Self-assembled silk sericin/poloxamer nanoparticles as nanocarriers of hydrophobic and hydrophilic drugs for targeted delivery.
Mandal BB; Kundu SC
Nanotechnology; 2009 Sep; 20(35):355101. PubMed ID: 19671963
[TBL] [Abstract][Full Text] [Related]
5. Antitumor efficacy of cisplatin-loaded glycol chitosan nanoparticles in tumor-bearing mice.
Kim JH; Kim YS; Park K; Lee S; Nam HY; Min KH; Jo HG; Park JH; Choi K; Jeong SY; Park RW; Kim IS; Kim K; Kwon IC
J Control Release; 2008 Apr; 127(1):41-9. PubMed ID: 18234388
[TBL] [Abstract][Full Text] [Related]
6. Preparation and characterization of water-soluble pH-sensitive nanocarriers for drug delivery.
Dufresne MH; Garrec DL; Sant V; Leroux JC; Ranger M
Int J Pharm; 2004 Jun; 277(1-2):81-90. PubMed ID: 15158971
[TBL] [Abstract][Full Text] [Related]
7. Towards multifunctional, targeted drug delivery systems using mesoporous silica nanoparticles--opportunities & challenges.
Rosenholm JM; Sahlgren C; Lindén M
Nanoscale; 2010 Oct; 2(10):1870-83. PubMed ID: 20730166
[TBL] [Abstract][Full Text] [Related]
8. Biodegradable nanoparticles based on linoleic acid and poly(beta-malic acid) double grafted chitosan derivatives as carriers of anticancer drugs.
Zhao Z; He M; Yin L; Bao J; Shi L; Wang B; Tang C; Yin C
Biomacromolecules; 2009 Mar; 10(3):565-72. PubMed ID: 19175304
[TBL] [Abstract][Full Text] [Related]
9. Mesoporous silica nanoparticles as a delivery system for hydrophobic anticancer drugs.
Lu J; Liong M; Zink JI; Tamanoi F
Small; 2007 Aug; 3(8):1341-6. PubMed ID: 17566138
[No Abstract] [Full Text] [Related]
10. Nanoimprint lithography based fabrication of shape-specific, enzymatically-triggered smart nanoparticles.
Glangchai LC; Caldorera-Moore M; Shi L; Roy K
J Control Release; 2008 Feb; 125(3):263-72. PubMed ID: 18053607
[TBL] [Abstract][Full Text] [Related]
11. Reversion of multidrug resistance by tumor targeted delivery of antisense oligodeoxynucleotides in hydroxypropyl-chitosan nanoparticles.
Wang J; Tao X; Zhang Y; Wei D; Ren Y
Biomaterials; 2010 May; 31(15):4426-33. PubMed ID: 20188412
[TBL] [Abstract][Full Text] [Related]
12. Selective targeting of antibody-conjugated nanoparticles to leukemic cells and primary T-lymphocytes.
Dinauer N; Balthasar S; Weber C; Kreuter J; Langer K; von Briesen H
Biomaterials; 2005 Oct; 26(29):5898-906. PubMed ID: 15949555
[TBL] [Abstract][Full Text] [Related]
13. The synergistic effect of hierarchical assemblies of siRNA and chemotherapeutic drugs co-delivered into hepatic cancer cells.
Cao N; Cheng D; Zou S; Ai H; Gao J; Shuai X
Biomaterials; 2011 Mar; 32(8):2222-32. PubMed ID: 21186059
[TBL] [Abstract][Full Text] [Related]
14. Synthesis of nanocarriers with remote magnetic drug release control and enhanced drug delivery for intracellular targeting of cancer cells.
Tung WL; Hu SH; Liu DM
Acta Biomater; 2011 Jul; 7(7):2873-82. PubMed ID: 21439410
[TBL] [Abstract][Full Text] [Related]
15. Hydrophobically modified glycol chitosan nanoparticles-encapsulated camptothecin enhance the drug stability and tumor targeting in cancer therapy.
Min KH; Park K; Kim YS; Bae SM; Lee S; Jo HG; Park RW; Kim IS; Jeong SY; Kim K; Kwon IC
J Control Release; 2008 May; 127(3):208-18. PubMed ID: 18336946
[TBL] [Abstract][Full Text] [Related]
16. HDL-mimicking peptide-lipid nanoparticles with improved tumor targeting.
Zhang Z; Chen J; Ding L; Jin H; Lovell JF; Corbin IR; Cao W; Lo PC; Yang M; Tsao MS; Luo Q; Zheng G
Small; 2010 Feb; 6(3):430-7. PubMed ID: 19957284
[TBL] [Abstract][Full Text] [Related]
17. [Nanoscale drug carriers for traditional Chinese medicine research and development].
Yi CX; Yu JN; Xu XM
Zhongguo Zhong Yao Za Zhi; 2008 Aug; 33(16):1936-40. PubMed ID: 19086622
[TBL] [Abstract][Full Text] [Related]
18. Thermoresponsive and biodegradable linear-dendritic nanoparticles for targeted and sustained release of a pro-apoptotic drug.
Stover TC; Kim YS; Lowe TL; Kester M
Biomaterials; 2008 Jan; 29(3):359-69. PubMed ID: 17964645
[TBL] [Abstract][Full Text] [Related]
19. Mesoporous silica nanoparticles for intracellular controlled drug delivery.
Vivero-Escoto JL; Slowing II; Trewyn BG; Lin VS
Small; 2010 Sep; 6(18):1952-67. PubMed ID: 20690133
[TBL] [Abstract][Full Text] [Related]
20. Novel biodegradable HSAM nanoparticle for drug delivery.
Liu B; Jiang S; Zhang W; Ye F; Wang YH; Wu J; Zhang DY
Oncol Rep; 2006 Apr; 15(4):957-61. PubMed ID: 16525685
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]